Rapid, simple, and sensitive analysis of relevant proteins is crucial in many research areas, such as clinical diagnosis and biomarker detection. In particular, clinical data on cancer biomarkers show great promise in forming reliable predictions for early cancer diagnostics, although the current analytical systems are difficult to implement in regions of limited recourses. Paper-based biosensors, in particular, have recently received great interest because they meet the criteria for point-of-care (PoC) devices; the main drawbacks with these devices are the low sensitivity and efficiency in performing quantitative measurements. In this work, we design a low-cost paper-based nanosensor through plasmonic calligraphy by directly drawing indivi...
Prostate cancer is commonly screened in the bloodstream by detection of excess PSA, prostate-specifi...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...
Plasmonic sensing has a great potential in the portable detection of human tumor markers, among whic...
Plasmonic sensing has a great potential in the portable detection of human tumor markers, among whic...
In this work, we design new plasmonic paper-based nanoplatforms with interesting capabilities in ter...
Efficient medical care fundamentally relies on the ability to provide a timely and accurate diagnosi...
There is an increasing interest in the development of novel biosensors in the foreseeable future.The...
Cancer is a major cause of mortality and morbidity worldwide. Detection and quantification of cancer...
Next-generation molecular diagnostic sensing systems seek to meet the needs of high-risk patients fo...
Point-of-care and in-field technologies for rapid, sensitive and selective detection of molecular bi...
cancer biomarkers; electrochemistry; inkjet-printed arrays; microfluidics; sensors Conventional prot...
Introduction: Optical biosensors, particularly those based on nanoplasmonics technology, have emerge...
In this work, we design new plasmonic paper-based nanoplatforms with interesting capabilities in ter...
[Introduction]: Optical biosensors, particularly those based on nanoplasmonics technology, have emer...
Prostate cancer is commonly screened in the bloodstream by detection of excess PSA, prostate-specifi...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...
Plasmonic sensing has a great potential in the portable detection of human tumor markers, among whic...
Plasmonic sensing has a great potential in the portable detection of human tumor markers, among whic...
In this work, we design new plasmonic paper-based nanoplatforms with interesting capabilities in ter...
Efficient medical care fundamentally relies on the ability to provide a timely and accurate diagnosi...
There is an increasing interest in the development of novel biosensors in the foreseeable future.The...
Cancer is a major cause of mortality and morbidity worldwide. Detection and quantification of cancer...
Next-generation molecular diagnostic sensing systems seek to meet the needs of high-risk patients fo...
Point-of-care and in-field technologies for rapid, sensitive and selective detection of molecular bi...
cancer biomarkers; electrochemistry; inkjet-printed arrays; microfluidics; sensors Conventional prot...
Introduction: Optical biosensors, particularly those based on nanoplasmonics technology, have emerge...
In this work, we design new plasmonic paper-based nanoplatforms with interesting capabilities in ter...
[Introduction]: Optical biosensors, particularly those based on nanoplasmonics technology, have emer...
Prostate cancer is commonly screened in the bloodstream by detection of excess PSA, prostate-specifi...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...
Development of point-of-care bioassays for sensitive screening of protein-based cancer biomarkers wo...